Rhythm Pharmaceuticals (RYTM)
Nasdaq • RYTM • US76243J1051
ORTEX Data Highlights
ORTEX Data Highlights
As of Nov 3, 2026, ORTEX estimates 18.7% of free float is sold short, 10.2 days to cover, cost to borrow 0.43%.
Market Cap
7.67b USD | # 2251 in US
Volume
833.38k shares | 83.6m USD
Shares Outstanding
68.85m
Free Float Shares
81.39% | 56.04m
